Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
Sponsor: Sanofi
Summary
The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in young children and adolescents who have first degree relatives with T1D. This protocol has been developed to address the growing need for standardized T1D screening, monitoring, and data collection in alignment with international recommendations. The study's estimated duration is 13 months and will consist of two visits: Visit 1 (screening visit) and Visit 2 (confirmatory visit).
Official title: Islet Autoantibody Early Detection in At-risk Children/Adolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries
Key Details
Gender
All
Age Range
18 Months - 18 Years
Study Type
INTERVENTIONAL
Enrollment
3500
Start Date
2025-12-17
Completion Date
2026-12-25
Last Updated
2026-02-19
Healthy Volunteers
Yes
Conditions
Interventions
Investigational Procedure
It consists of prospective blood sample collection from children, adolescents and first-degree relatives of T1D probands. Study without any Investigational Medicinal Product (IMP) administration.
Locations (2)
King Abdulaziz Medical City, National Guard Hospital, Jeddah - Site Number: 01
Jeddah, Mecca Region, Saudi Arabia
Sheikh Shakhbout Medical City - Site Number: 06
Abu Dhabi, United Arab Emirates